Address
304 North Cardinal St.
Dorchester Center, MA 02124
Work Hours
Monday to Friday: 7AM - 7PM
Weekend: 10AM - 5PM
Distressed Public Equities
TitanIvy allocates capital towards distressed publicly traded companies. We take controlled position and orchestrate the company’s turnaround.
What We Do
TitanIvy International is a global crossover / pre-IPO fund managed by a team that has collectively achieved exits worth over $20 Billion+.
Pre-IPO Private Equity
Selectively invest in pre-IPO and IPO headed growth equity rounds of companies in our network
Crossover Investments
TitanIvy boasts expertise in diverse exit strategies, including IPOs, reverse mergers, and direct listings across global exchanges
SPAC Sponsoring
Significant expertise Investing in TitanIvy-backed SPACs, IPOs, and other alternative public vehicles
Public Company Turnarounds
Expertise taking controlled position and orchestrating company
turnarounds.
Distressed Public Equities
Allocate capital towards
operationally sound “toxic debt” & distressed publicly traded companies
Invest in IPOs
Take positions in PIPEs, convertible securities, Last-in/First-out positions and common stocks of companies at the time of the IPO or de-SPAC
Team Strength
Extensive Public and Private Markets
Experience & Strong Operational Expertise
Extensive expertise in steering the operations of
publicly traded companies & current and past engagements have involved pivotal roles as Chairman, CEO, and Board Members in notable organizations, including The Bancorp, ApolloMed, Clinigence Holdings,
and Cardio Diagnostics.
$5 Billion+ in de-SPACs
Have been involved with 10 SPACs, raising a
total of $2 billion+ in capital, successful closure
and announcement of 7 de-SPAC transactions,
totaling a transaction value of $5 billion+
ApolloMed IPO
Co-founded ApolloMed (NASDAQ: AMEH),
completed IPO in 2008, raised over $200
million in capital. Peak market cap of $1.4
billion during Warren’s tenure. Private
placement investors generated 28x+ their
investments
Bancorp IPO
Co-founded The Bancorp, led the company
through its IPO in 2000. Under Frank’s
leadership, from 1999 to 2006, the stock price
surged from $9.50 to $28.50, a return of 200%+
Do you have any question?
Feel free to contact us.
Why Our Team Stands Out
Our seasoned team boasts decades of experience successfully operating both public and private enterprises, We possess exclusive deal flow in a fiercely competitive environment.
Forward-looking vision with deep innovation experience
Uniquely positioned with a proprietary angle
Understand value creation and strategic opportunities
Deep resources, domain experience and expertise